40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
12.15%
Revenue growth exceeding 1.5x CRK's 4.51%. David Dodd would verify if faster growth reflects superior business model.
16.28%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
9.37%
Gross profit growth below 50% of CRK's 44.36%. Michael Burry would check for structural issues.
-2.47%
Margin decline while CRK shows 38.13% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.25%
Other expenses growth less than half of CRK's 185.37%. David Dodd would verify if advantage is sustainable.
19.00%
Operating expenses growth less than half of CRK's 234.89%. David Dodd would verify sustainability.
17.29%
Total costs growth less than half of CRK's 96.79%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-0.85%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-38.64%
EBITDA decline while CRK shows 50.54% growth. Joel Greenblatt would examine position.
16.43%
EBITDA margin growth while CRK declines. John Neff would investigate advantages.
3.15%
Operating income growth below 50% of CRK's 83.08%. Michael Burry would check for structural issues.
-8.02%
Operating margin decline while CRK shows 75.18% growth. Joel Greenblatt would examine position.
96.83%
Other expenses growth above 1.5x CRK's 55.91%. Michael Burry would check for concerning trends.
-63.39%
Pre-tax income decline while CRK shows 236.32% growth. Joel Greenblatt would examine position.
-67.36%
Pre-tax margin decline while CRK shows 230.44% growth. Joel Greenblatt would examine position.
-55.53%
Tax expense reduction while CRK shows 249.94% growth. Joel Greenblatt would examine advantage.
-68.39%
Net income decline while CRK shows 229.97% growth. Joel Greenblatt would examine position.
-71.81%
Net margin decline while CRK shows 224.36% growth. Joel Greenblatt would examine position.
-67.71%
EPS decline while CRK shows 227.74% growth. Joel Greenblatt would examine position.
-68.09%
Diluted EPS decline while CRK shows 220.44% growth. Joel Greenblatt would examine position.
-1.94%
Share count reduction while CRK shows 1.69% change. Joel Greenblatt would examine strategy.
-1.81%
Diluted share reduction while CRK shows 6.58% change. Joel Greenblatt would examine strategy.